Eleven Biotherapeutics CEO Thomas Cannell's 2020 pay jumps 21% to $1.7M
Eleven Biotherapeutics reports 2020 executive compensation
By ExecPay News
Published: March 25, 2021
Eleven Biotherapeutics reported fiscal year 2020 executive compensation information on March 25, 2021.
In 2020, three executives at Eleven Biotherapeutics received on average a compensation package of $1.1M, a 18% increase compared to previous year.
Average pay of disclosed executives at Eleven Biotherapeutics
Thomas R. Cannell, Chief Executive Officer, received $1.7M in total, which increased by 21% compared to 2019. 48% of Cannell's compensation, or $817K, was in option awards. Cannell also received $348K in non-equity incentive plan, $533K in salary, as well as $4K in other compensation.
Monica Forbes, Chief Financial Officer, received a compensation package of $795K, which increased by 18% compared to previous year. 45% of the compensation package, or $361K, was in salary.
Glen MacDonald, Chief Technology Officer, earned $675K in 2020, a 16% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 25, 2021.